Thromboembolism and Janus Kinase Inhibitors Fowzia IbrahimDavid L. Scott Commentary 16 July 2020 Pages: 831 - 833
Use of Social Media for Pharmacovigilance Activities: Key Findings and Recommendations from the Vigi4Med Project Bissan AudehFlorelle BelletCédric Bousquet Special Article 16 June 2020 Pages: 835 - 851
Drug Safety in Geriatric Patients: Current Status and Proposed Way Forward Giovanni FurlanPia Caduff-JanosaMarco Tuccori Leading Article 04 June 2020 Pages: 853 - 866
Pathophysiology of Drug-Induced Hypomagnesaemia Periklis KatopodisEmmanouil KarterisKonstantinos P. Katopodis Review Article 12 May 2020 Pages: 867 - 880
Thromboembolic Safety Reporting of Tofacitinib and Baricitinib: An Analysis of the WHO VigiBase Enriqueta Vallejo-YagüeStefan WeilerAndrea M. Burden Original Research Article 12 June 2020 Pages: 881 - 891
Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions Ying LiAntonio Jimeno YepesCao Xiao Original Research Article Open access 08 May 2020 Pages: 893 - 903
Information Visualization Platform for Postmarket Surveillance Decision Support Jonathan SpikerKory KreimeyerTaxiarchis Botsis Original Research Article 22 May 2020 Pages: 905 - 915
Patient-Reported Burden of Adverse Drug Reactions Attributed to Biologics Used for Immune-Mediated Inflammatory Diseases Jette A. van LintNaomi T. JessurunBart J. F. van den Bemt Original Research Article 25 May 2020 Pages: 917 - 925
Channeling Bias in the Analysis of Risk of Myocardial Infarction, Stroke, Gastrointestinal Bleeding, and Acute Renal Failure with the Use of Paracetamol Compared with Ibuprofen Rachel B. WeinsteinPatrick B. RyanDaniel Fife Original Research Article Open access 04 June 2020 Pages: 927 - 942
Association Between Intravitreal Aflibercept and Serious Non-ocular Haemorrhage Compared with Intravitreal Ranibizumab: A Multicentre Observational Cohort Study Janet SultanaFrancesco GiorgianniGianluca Trifirò Original Research Article 16 June 2020 Pages: 943 - 952